Skip to main content
. 2021 May 5;13:3639–3650. doi: 10.2147/CMAR.S254671

Figure 1.

Figure 1

The expression of miR-139-5p and YAF2mRNA in NSCLC. (A), The expression of miR-139-5p in NSCLC tissues. (B), The expression of YAF2 mRNA in NSCLC tissues. (C), The expression of miR-139-5p in NSCLC cells. (D), The expression of YAF2mRNA in NSCLC cells. (E), Correlation analysis between miR-139-5p and YAF2 in NSCLC. (F), Effects of miR-139-5p on the prognosis of NSCLC patients. *Indicates P<0.05.